Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma

被引:22
|
作者
Gyongyossy-Issa, M. I. C. [2 ]
Zhang, J. G. [2 ]
Culibrk, B. [2 ]
Hunter, F.
Levin, E. [2 ]
Scammell, K.
Weiss, S.
Holmes, D. L. [1 ]
Holme, S. [1 ]
机构
[1] Pall Med, Covina, CA USA
[2] UBC Ctr Blood Res, Canadian Blood Serv, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
platelet storage; platelet additive solution; PAS-G; buffy-coat platelets; platelet metabolism; IN-VITRO; SYNTHETIC MEDIUM; NEW-GENERATION; SOLUTION-II; TRANSFUSION; IMPLEMENTATION; MULTICENTER; EXPERIENCE; POTASSIUM; MAGNESIUM;
D O I
10.1111/j.1423-0410.2009.01196.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In Europe, buffy-coat processing allows for the use of platelet additive solutions (PAS). These solutions, however, have long been questioned for their lack of glucose, a potentially essential nutrient for platelet storage. Using a novel, practical, two-part system for incorporation of glucose into an additive solution (PAS-G), this study compares platelet storage in plasma to storage in PAS-G. Study Design and Methods A paired study design of platelet concentrates (PC) were prepared from leucoreduced pools of eight buffy coats (BCP) split into two equal pools, with suspension in autologous plasma, or PAS-G. On days 2, 5, 7 and 9 of storage, samples were tested using standard in vitro platelet parameters. Data were analysed by paired Student's t-tests. Results During storage, PCs in PAS-G maintain a quality profile that is strikingly similar to PCs stored in plasma in terms of platelet activation (CD62) morphology score, swirl, glucose metabolism and pH. However, PCs in PAS-G perform lower (P < 0 center dot 05) in the %ESC and %HSR assays. Conclusion PAS-G's novel presentation allows incorporation of glucose into the additive solution so that it is roughly equivalent to plasma for the maintenance of buffy-coat PCs.
引用
收藏
页码:102 / 109
页数:8
相关论文
共 50 条
  • [41] In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags
    Cardigan, R.
    Sutherland, J.
    Garwood, M.
    Bashir, S.
    Turner, C.
    Smith, K.
    Hancock, V.
    Wiltshire, M.
    Pergande, C.
    Williamson, L. M.
    VOX SANGUINIS, 2008, 94 (02) : 103 - 112
  • [42] Storage of buffy-coat-derived platelets in additive solutions at 4°C and 22°C:: flow cytometry analysis of platelet glycoprotein expression (vol 93, pg 27, 2007)
    Sandgren, Per
    Hansson, Mona
    Gulliksson, Hans
    Shanwell, Agenta
    VOX SANGUINIS, 2008, 94 (01) : 86 - 86
  • [43] In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions
    Gravemann, Ute
    Volgmann, Thorsten
    Min, Kyungyoon
    Philipp, Roman
    Lambrecht, Bernd
    Mueller, Thomas H.
    Seltsam, Axel
    TRANSFUSION, 2015, 55 (07) : 1700 - 1709
  • [44] STORAGE OF BUFFY-COAT-DERIVED PLATELETS IN ADDITIVE SOLUTIONS: IN VITRO EFFECTS ON PLATELETS PREPARED BY THE NOVEL TACSI SYSTEM AND STORED IN PLASTIC CONTAINERS WITH DIFFERENT GAS PERMEABILITY
    Sandgren, P.
    Hild, M.
    Sjodin, A.
    Gulliksson, H.
    VOX SANGUINIS, 2010, 99 : 191 - 191
  • [45] In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step
    Abonnenc, Melanie
    Sonego, Giona
    Kaiser-Guignard, Julie
    Crettaz, David
    Prudent, Michel
    Tissot, Jean-Daniel
    Lion, Niels
    BLOOD TRANSFUSION, 2015, 13 (02) : 255 - 264
  • [46] Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability
    Sandgren, P.
    Hild, M.
    Sjodin, A.
    Gulliksson, H.
    VOX SANGUINIS, 2010, 99 (04) : 341 - 347
  • [47] In Vitro Variables of Buffy Coat-derived Platelet Concentrates with Residual Plasma levels of down to 10% are Stably Maintained in Late-Generation Platelet Additive Solutions
    Gravemann, U.
    Volgmann, T.
    Philipp, R.
    Lambrecht, B.
    Mueller, T. H.
    Seltsam, A.
    TRANSFUSION, 2014, 54 : 96A - 97A
  • [48] Glucose ameliorates the metabolic profile and mitochondrial function of platelet concentrates during storage in autologous plasma
    Amorini, Angela M.
    Tuttobene, Michele
    Tomasello, Flora M.
    Biazzo, Filomena
    Gullotta, Stefano
    De Pinto, Vito
    Lazzarino, Giuseppe
    Tavazzi, Barbara
    BLOOD TRANSFUSION, 2013, 11 (01) : 61 - 70
  • [49] Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma
    de Wit, Yasmin E. S.
    Vlaar, Richard
    Gouwerok, Eric
    Hamzeh-Cognasse, Hind
    van Mierlo, Gerard
    Bulder, Ingrid
    Lagerberg, Johan W. M.
    de Korte, Dirk
    Cognasse, Fabrice
    ten Brinke, Anja
    Zeerleder, Sacha S.
    BLOOD TRANSFUSION, 2023, 21 (02) : 157 - 167
  • [50] Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over
    Sandgren, P.
    Mayaudon, V.
    Payrat, J-M.
    Sjodin, A.
    Gulliksson, H.
    VOX SANGUINIS, 2010, 98 (03) : 415 - 422